Despite the association with sudden cardiac death, mitral valve prolapse (MVP) syndrome has largely been viewed as a benign condition and contemporary management continues to advocate reassurance and lifestyle changes.

In this Cardiology article, Edward Chu, MD, writes that for individuals who suffer from the recurrent, disabling symptoms of MVP syndrome and fear its potentially lethal consequences, these medical recommendations have been confusing and insufficient, leading patients to publish their own experiences as they explore unconventional treatment strategies. Read more.

Follow Cardiology on Twitter using #CardiologyMag and get the full issue here.